SEVELAMER

Clinical Indication

Hyperphosphataemia

Date of classification

May 2015

Review date

May 2015

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.